Here, we demonstrate that upregulation of p62 expression in SCC cells in vitro and in carcinomas represents a second pathway that antagonizes the NLRP1 inflammasome, suggesting that NLRP1 suppression in SCCs is relevant for cancer development. Here, NLRP1 is linked to carcinoma.